Eye scans to check liver disease and transplant outlook
Part of Digestive system, Eyes & vision clinical trials.
This study uses advanced eye scans to see if your eyes can give clues about your chronic liver disease and how well you might do after a liver transplant. If you have advanced liver disease or cirrhosis, and are maybe waiting for a transplant, you may join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have advanced liver disease or cirrhosis, and may be waiting for a liver transplant.
- You must be able to have standard blood tests, imaging, and a liver biopsy (if needed).
- You can cooperate with eye exams like OCT (a special scan of the back of the eye).
- You cannot have had a previous organ transplant (other than liver).
- You cannot have serious eye diseases like glaucoma or high nearsightedness, or previous eye surgeries/laser/injections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is creating a database of people with severe liver problems or who have had a liver transplant. The goal is to learn more about these conditions and improve care.
This study uses non-invasive tests, like scans or blood tests, to predict how well people with liver cancer (hepatocellular carcinoma, or HCC) will do after curative treatment. It may help doctors better understand your condition without needing invasive procedures.
This study follows people with advanced chronic liver disease to understand how their condition changes over time. If you have cirrhosis or high liver stiffness, you may be able to join to help researchers track the disease and learn more about it.
This study looks at non-invasive tests (tests that don’t require surgery) to see whether they can diagnose and predict how chronic liver disease will worsen over time. If you may have chronic liver disease, these tests could help doctors follow your condition more accurately.
This trial is testing a new way to see how well patients do after a liver transplant. It includes people with severe cirrhosis, other end-stage liver diseases, or liver cancer.
This study looks at how well noninvasive tests (tests that don’t require surgery or taking tissue) can detect complications after a liver transplant. It may help patients and teams find problems earlier using safer, easier monitoring.
Hear when a new Liver Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.